The North America PEGylated Proteins Market would witness market growth of 10.6% CAGR during the forecast period (2022-2028).
Out of a projected 29.5 million new cases of the disease each year, 16.4 million individuals are anticipated to pass away from cancer-related causes by 2040. In addition, as per the fact sheet from the Joint United Nations Program on HIV/AIDS estimates that 37.7 million persons were HIV-positive globally in 2020. (UNAIDS).
As a result, the burden of infectious and chronic diseases worldwide is expected to increase, increasing the demand for generating medicines. The expansion of the sector will be accelerated, and research will be encouraged. It is expected that COVID-19 will have a beneficial impact on the sector. In SARS-CoV-2 ICU patients, PEGylated Nanoparticle Albumin-Bound (PNAB)-steroidal.
Ginsenoside can successfully lower plasma levels of histone H4 and NETosis-Related Factors and reduce SREBP2-Mediated Systemic Inflammation, according to a study titled "PEGylated Nanoparticle Albumin-Bound Steroidogenic Ginsenoside. Derivatives Alleviate SARS PNAB-steroidal ginsenoside medications may be used to treat severe SARS-CoV-2 patients' common coagulation and cytokine storm symptoms. Given the extensive research operations using PEGylation technology, the COVID-19 pandemic had a positive effect on the industry.
In Canada and the USA, cancer is the second-leading cause of mortality, behind heart disease. In Northern America, it was anticipated that there would be 1.9 million new cancer diagnoses and 693,000 cancer deaths in 2018. While lung cancer continues to be the most prevalent cause of cancer death in both sexes, prostate and breast cancer are the most often diagnosed cancers in men and women, respectively.
The US market dominated the North America PEGylated Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $533.2 million by 2028.The Canada market is exhibiting a CAGR of 13.1% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 12.1% during (2022 - 2028).
Based on Product & Services, the market is segmented into Consumables and Services. Based on Type, the market is segmented into Colony-stimulating Factor, Interferons, Recombinant Factor VII, Erythropoietin and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic & Research Institutes. Based on Application, the market is segmented into Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global PEGylated Proteins Market is Estimated to reach $2.1 Billion by 2028, at a CAGR of 11.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Millipore (Merck KGaA), Thermo Fisher Scientific, Inc., NOF Corporation, JenKem Technology Co. Ltd., Creative PEGworks, Celares GmbH, Quanta BioDesign, Ltd., Biomatrik, Inc., Iris Biotech GmbH, and Laysan Bio, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product & Services
By Type
- Colony-stimulating Factor
- Interferons
- Recombinant Factor VII
- Erythropoietin
- Others
By End-user
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
By Application
- Cancer
- Autoimmune Diseases
- Hepatitis
- Multiple Sclerosis
- Hemophilia
- Gastrointestinal Disorders
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Merck Millipore (Merck KGaA)
- Thermo Fisher Scientific, Inc.
- NOF Corporation
- JenKem Technology Co. Ltd.
- Creative PEGworks
- Celares GmbH
- Quanta BioDesign, Ltd.
- Biomatrik, Inc.
- Iris Biotech GmbH
- Laysan Bio, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America PEGylated Proteins Market, by Product & Services
1.4.2 North America PEGylated Proteins Market, by Type
1.4.3 North America PEGylated Proteins Market, by End-user
1.4.4 North America PEGylated Proteins Market, by Application
1.4.5 North America PEGylated Proteins Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in PEGylated Proteins Market
Chapter 4. North America PEGylated Proteins Market by Product & Services
4.1 North America Consumables Market by Country
4.2 North America Services Market by Country
Chapter 5. North America PEGylated Proteins Market by Type
5.1 North America Colony-stimulating Factor Market by Country
5.2 North America Interferons Market by Country
5.3 North America Recombinant Factor VII Market by Country
5.4 North America Erythropoietin Market by Country
5.5 North America Others Market by Country
Chapter 6. North America PEGylated Proteins Market by End-user
6.1 North America Pharmaceutical & Biotechnology Companies Market by Country
6.2 North America Contract Research Organizations (CROs) Market by Country
6.3 North America Academic & Research Institutes Market by Country
Chapter 7. North America PEGylated Proteins Market by Application
7.1 North America Cancer Market by Country
7.2 North America Autoimmune Diseases Market by Country
7.3 North America Hepatitis Market by Country
7.4 North America Multiple Sclerosis Market by Country
7.5 North America Hemophilia Market by Country
7.6 North America Gastrointestinal Disorders Market by Country
7.7 North America Others Market by Country
Chapter 8. North America PEGylated Proteins Market by Country
8.1 US PEGylated Proteins Market
8.1.1 US PEGylated Proteins Market by Product & Services
8.1.2 US PEGylated Proteins Market by Type
8.1.3 US PEGylated Proteins Market by End-user
8.1.4 US PEGylated Proteins Market by Application
8.2 Canada PEGylated Proteins Market
8.2.1 Canada PEGylated Proteins Market by Product & Services
8.2.2 Canada PEGylated Proteins Market by Type
8.2.3 Canada PEGylated Proteins Market by End-user
8.2.4 Canada PEGylated Proteins Market by Application
8.3 Mexico PEGylated Proteins Market
8.3.1 Mexico PEGylated Proteins Market by Product & Services
8.3.2 Mexico PEGylated Proteins Market by Type
8.3.3 Mexico PEGylated Proteins Market by End-user
8.3.4 Mexico PEGylated Proteins Market by Application
8.4 Rest of North America PEGylated Proteins Market
8.4.1 Rest of North America PEGylated Proteins Market by Product & Services
8.4.2 Rest of North America PEGylated Proteins Market by Type
8.4.3 Rest of North America PEGylated Proteins Market by End-user
8.4.4 Rest of North America PEGylated Proteins Market by Application
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.2 Merck Millipore ( Merck Group)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.3 NOF Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Beijing Jiankai Technology Co., Ltd. (Jenkem)
9.4.1 Company Overview
9.5 Creative PEGworks
9.5.1 Company Overview
9.6 Celares GmbH
9.6.1 Company Overview
9.7 Quanta BioDesign Ltd.
9.7.1 Company Overview
9.8 Biomatrik, Inc.
9.8.1 Company Overview
9.9 Iris Biotech GmbH
9.9.1 Company Overview
9.10. Laysan Bio, Inc.
9.10.1 Company Overview
TABLE 1 North America PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 2 North America PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 3 North America PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 4 North America PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 5 North America Consumables Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Consumables Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Services Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Services Market by Country, 2022 - 2028, USD Million
TABLE 9 North America PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 10 North America PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 11 North America Colony-stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Colony-stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Interferons Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Interferons Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Recombinant Factor VII Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Recombinant Factor VII Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 21 North America PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 22 North America PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 23 North America Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 29 North America PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 30 North America PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 31 North America Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Hepatitis Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Hepatitis Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Gastrointestinal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Gastrointestinal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 45 North America PEGylated Proteins Market by Country, 2018 - 2021, USD Million
TABLE 46 North America PEGylated Proteins Market by Country, 2022 - 2028, USD Million
TABLE 47 US PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 48 US PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 49 US PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 50 US PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 51 US PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 52 US PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 53 US PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 54 US PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 55 US PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 56 US PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 57 Canada PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 58 Canada PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 59 Canada PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 60 Canada PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 61 Canada PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 62 Canada PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 63 Canada PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 64 Canada PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 65 Canada PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 66 Canada PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 67 Mexico PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 68 Mexico PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 69 Mexico PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 70 Mexico PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 71 Mexico PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 72 Mexico PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 73 Mexico PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 74 Mexico PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 75 Mexico PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 76 Mexico PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 77 Rest of North America PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 78 Rest of North America PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 79 Rest of North America PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 80 Rest of North America PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 81 Rest of North America PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 82 Rest of North America PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 83 Rest of North America PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 84 Rest of North America PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 85 Rest of North America PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 86 Rest of North America PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 Key Information – Merck Millipore
TABLE 89 Key Information – nof corporation
TABLE 90 Key Information – Beijing Jiankai Technology Co., Ltd.
TABLE 91 Key Information – Creative PEGworks
TABLE 92 Key Information – Celares gmbh
TABLE 93 Key Information –Quanta biodesign ltd.
TABLE 94 Key Information – biomatrik, inc.
TABLE 95 Key Information – Iris biotech gmbh
TABLE 96 Key Information – laysan bio, inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Thermo Fisher Scientific, Inc.